United Front Intl
No Result
View All Result
Tuesday, February 7, 2023
  • Login
  • Register
  • Home
  • US
  • World
  • Politics
  • Coronavirus
  • Videos
  • Be in the Know
  • ShopNew
Contact us
United Front Intl
  • Home
  • US
  • World
  • Politics
  • Coronavirus
  • Videos
  • Be in the Know
  • ShopNew

No products in the cart.

No Result
View All Result
United Front Intl
No Result
View All Result
Home Coronavirus

Blood-clot risk unchanged after second Oxford/AstraZeneca vaccine shot: Study

Study confirms most blood clotting issues occur after the first dose.

by admin
July 28, 2021
in Be in the Know, Coronavirus
Blood-clot risk unchanged after second Oxford/AstraZeneca vaccine shot: Study

Countries have raised concerns over the AstraZeneca vaccine | Hector Vivas/Getty Images

Share on FacebookShare on Twitter

POLITICO
BY JILLIAN DEUTSCH AND ASHLEIGH FURLONG

A person’s risk of blood clots doesn’t increase after the second Oxford/AstraZeneca coronavirus vaccine shot, according to a new study from AstraZeneca.

The company is trying to boost confidence in its jab, which has taken a beating after reports of rare but serious blood clotting events after vaccination. The study, published this week in the Lancet, could boost people’s confidence in receiving their second dose.

However, the study also confirmed previous reports from regulators that the majority of blood clotting incidents occurred two weeks after the first dose of the viral vector vaccine.

For every million people who received a first shot, there were 8.1 reports of thrombosis with thrombocytopenia syndrome (TTS) — blood clots with low blood platelets. The study looked at a total of 49.23 million people who received the vaccine in the EU, the European Economic Area and the U.K. by the end of April.

After the second dose, there were 2.3 cases out of every million people that reported blood clotting issues. That sample covers 5.62 million who received their second shot within the same time frame.

The company said there were “no specific risk factors or [a] definitive cause” for blood clotting issues associated with its vaccine, developed in partnership with the University of Oxford, and noted it’s continuing to investigate possible causes.

Countries have raised concerns over the vaccine, especially in the EU, where many are only using the vaccine in older populations or donating doses abroad. AstraZeneca claimed this trend could have affected reports of adverse events, writing in the study said that “heightened media attention might have led to event misclassification.”

The vaccine “plays a critical role in combating the pandemic,” Mene Pangalos, AstraZeneca’s executive vice president for biopharmaceuticals R&D, wrote in a statement.

“Unless TTS was identified after the first dose, these results support the administration of the two-dose schedule of [the vaccine] as indicated, to help provide protection against COVID-19 including against rising variants of concern,” Pangalos said.

Related

ShareTweetSendSend

Related Posts

The border buses: New York City’s migrant crisis | States of America
Videos

The border buses: New York City’s migrant crisis | States of America

January 30, 2023
What is known about new Covid variant XBB.1.5?
Coronavirus

What is known about new Covid variant XBB.1.5?

January 17, 2023
GIVING TUESDAY 2022
Be in the Know

GIVING TUESDAY 2022

November 29, 2022
Explainer: COVID, flu and RSV this U.S. winter: Why experts are worried
Coronavirus

Explainer: COVID, flu and RSV this U.S. winter: Why experts are worried

October 27, 2022
Ukrainian Refugees Arrive In Reproductive Rights Nightmare
Videos

Ukrainian Refugees Arrive In Reproductive Rights Nightmare

September 2, 2022
How Russia Profits From African Coups
Videos

How Russia Profits From African Coups

August 27, 2022

My Cart

No Content Available

Categories

  • Be in the Know
  • Coronavirus
  • Politics
  • US
  • Videos
  • World

UnitedFrontIntl Store

My Account & Ordering
Cart
Checkout
Track My Order
Refund and Returns Policy
Privacy Policy
FAQs

Site Navigation

  • Home
  • Advertise
  • Contact Us
  • Jobs
  • About Us
  • Shipping Policy

Links

CNBC
Reuters

The New York Times
The Washington Post


Your tax-deductible gift is vital and will help us fund and maintain our website to bring you current news and information on a daily basis. Thank you in advance.

© 2022 United Front Intl

No Result
View All Result
  • Home
  • US
  • World
  • Politics
  • Coronavirus
  • Videos
  • Be in the Know
  • Contact Us
  • Advertisement
  • Shop

© 2022 United Front Intl

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In